| Literature DB >> 31320894 |
Débora Apª O Modena1,2, Caroline Nogueira da Silva2, Talita C P Delinocente3, Tatiane Bianca de Araújo3, Tania Maria de Carvalho1, Clovis Grecco2, Renata Gomes Moreira2, Gisele Campos4, José Ricardo de Souza2, Renata Michelini Guidi1,2.
Abstract
In the past centuries, the human body was undervalued; nowadays, however, it is overvalued, and thus the manifestation of the dissatisfactions regarding the body has been increasing. Most of the time, these dissatisfactions are related to cellulite, which is most common in women. Its treatment is one of the challenges which encourage the development of new therapeutic modalities, among them the shockwave therapy. Objective. To evaluate the efficacy of ESWT in the treatment of cellulite in gluteus and posterior of thigh. Method. This is a prospective and comparative study, in which volunteer women who attended the criteria of inclusion were selected and who were subjected to 10 sessions of ESWT. The following were performed as an evaluation method: anthropometry, perimetry, skin viscoelasticity with the Cutometer®, thickness of hypodermis with diagnostic ultrasound, analysis of the scale of severity of cellulite (CSS), and quality of life by the Celluqol® questionnaire. The evaluations occurred before the first session (baseline), after 6 and 10 sessions, and during a follow-up of 3 months after the last session. The statistical test applied was the ANOVA one-way with post hoc of Tukey (P-value < 0.05). Results. There was significant improvement (P<0.05) for CSS, for the variable referring to gross elasticity and skin deformation ability evaluated in the Cutometer® and improvement of quality of life represented by Celluqol®. The result was maintained particularly in the follow-up of 3 months after the end of the treatment. Conclusion. The results presented demonstrated the effectiveness and safety of ESWT in the treatment of cellulite and in the decrease of the degrees, improvement of the aspect of the skin, and reestablishment of quality of life. This trial is registered with ClinicalTrials: NCT03275259.Entities:
Year: 2019 PMID: 31320894 PMCID: PMC6609368 DOI: 10.1155/2019/8246815
Source DB: PubMed Journal: Dermatol Res Pract ISSN: 1687-6113
Figure 1Improvement in the severity of cellulite between the initial evaluation, reevaluations, and follow-up of 3 months from the end of the treatment.
Figure 2Improvement of the degrees of cellulite in different views in the comparison of the photos throughout the evaluations and reevaluations.
Figure 3Improvement of quality of life by the representation of the Celluqol® questionnaire.